Literature DB >> 1353216

Cutaneous anthrax due to penicillin-resistant Bacillus anthracis transmitted by an insect bite.

N Bradarić, V Punda-Polić.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1353216     DOI： 10.1016/0140-6736(92)92395-v

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.

Authors:  Henry S Heine; Jennifer Bassett; Lynda Miller; Bret K Purcell; W Russell Byrne
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

2.  Beta-lactamase gene expression in a penicillin-resistant Bacillus anthracis strain.

Authors:  Yahua Chen; Fred C Tenover; Theresa M Koehler
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence.

Authors:  Joanne E Thwaite; Stephen Hibbs; Richard W Titball; Timothy P Atkins
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.

Authors:  David Kobiler; Yehoshua Gozes; Hagai Rosenberg; Dino Marcus; Shaul Reuveny; Zeev Altboum
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon.

Authors:  Silke R Klee; Muhsin Ozel; Bernd Appel; Christophe Boesch; Heinz Ellerbrok; Daniela Jacob; Gudrun Holland; Fabian H Leendertz; Georg Pauli; Roland Grunow; Herbert Nattermann
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

6.  Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs.

Authors:  Zeev Altboum; Yehoshua Gozes; Ada Barnea; Avi Pass; Moshe White; David Kobiler
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity.

Authors:  Yu-hua Xing; Wei Wang; Su-qin Dai; Ti-yan Liu; Jun-jie Tan; Guo-long Qu; Yu-xia Li; Yan Ling; Gang Liu; Xue-qi Fu; Hui-peng Chen
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

8.  Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997.

Authors:  G Patra; J Vaissaire; M Weber-Levy; C Le Doujet; M Mock
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

9.  Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.

Authors:  H S Heine; J Bassett; L Miller; A Bassett; B E Ivins; D Lehoux; F F Arhin; T R Parr; G Moeck
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

10.  Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model.

Authors:  Henry S Heine; Bret K Purcell; Jennifer Bassett; Lynda Miller; Beth P Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.